The role of anti-IgE in managing difficult-to-treat or severe asthma.
Until recently, treatment options for those with severe or difficult-to-treat asthma have been restricted to the use of beta 2-agonists and corticosteroids. It has been increasingly recognised that such patients need a new approach. This article discusses how anti-immunoglobulin E treatment could contribute to the successful management of patients with this condition.
Pearce
L
L
West Suffolk Hospital, Bury St Edmunds, Suffolk.
D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D001249:Asthma / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive; D007073:Immunoglobulin E / Q000276:immunology*
D000888:Antibodies, Anti-Idiotypic; C026408:anti-IgE antibodies; D007073:Immunoglobulin E